Cumberland Partners’s Thermo Fisher Scientific TMO Stock Holding History
Bought
Maintained
Sold
Quarter | Market Value | Status | Shares |
Shares Change % | Capital Flow | Portfolio Weight | Portfolio Position | |
---|---|---|---|---|---|---|---|---|
2025
Q2 | $345K | Sell |
850
-33,573
| -98% | -$13.6M | 0.02% | 159 |
|
2025
Q1 | $17.1M | Sell |
34,423
-272
| -0.8% | -$135K | 1.32% | 24 |
|
2024
Q4 | $18M | Sell |
34,695
-73
| -0.2% | -$38K | 1.26% | 25 |
|
2024
Q3 | $21.5M | Sell |
34,768
-14,600
| -30% | -$9.03M | 1.49% | 22 |
|
2024
Q2 | $27.3M | Sell |
49,368
-1,369
| -3% | -$757K | 1.99% | 18 |
|
2024
Q1 | $29.5M | Buy |
50,737
+877
| +2% | +$510K | 2.14% | 18 |
|
2023
Q4 | $25.3M | Sell |
49,860
-745
| -1% | -$378K | 2.31% | 17 |
|
2023
Q3 | $25.6M | Sell |
50,605
-1,213
| -2% | -$614K | 2.46% | 17 |
|
2023
Q2 | $27M | Sell |
51,818
-715
| -1% | -$373K | 2.48% | 15 |
|
2023
Q1 | $30.3M | Sell |
52,533
-922
| -2% | -$531K | 2.97% | 9 |
|
2022
Q4 | $29.4M | Sell |
53,455
-4,022
| -7% | -$2.21M | 3.1% | 9 |
|
2022
Q3 | $29.2M | Buy |
57,477
+2,080
| +4% | +$1.05M | 3.1% | 8 |
|
2022
Q2 | $30.1M | Sell |
55,397
-3,333
| -6% | -$1.81M | 2.87% | 10 |
|
2022
Q1 | $34.7M | Buy |
58,730
+95
| +0.2% | +$56.1K | 2.62% | 11 |
|
2021
Q4 | $39.1M | Buy |
58,635
+2,415
| +4% | +$1.61M | 2.75% | 7 |
|
2021
Q3 | $32.1M | Buy |
56,220
+794
| +1% | +$454K | 2.63% | 8 |
|
2021
Q2 | $28M | Sell |
55,426
-3,918
| -7% | -$1.98M | 2.19% | 10 |
|
2021
Q1 | $27.1M | Sell |
59,344
-1,023
| -2% | -$467K | 2.23% | 12 |
|
2020
Q4 | $28.1M | Sell |
60,367
-1,214
| -2% | -$565K | 2.52% | 10 |
|
2020
Q3 | $27.2M | Buy |
61,581
+1,363
| +2% | +$602K | 2.84% | 9 |
|
2020
Q2 | $21.8M | Buy |
60,218
+2,657
| +5% | +$963K | 2.26% | 12 |
|
2020
Q1 | $16.3M | Sell |
57,561
-2,343
| -4% | -$664K | 1.96% | 17 |
|
2019
Q4 | $19.5M | Buy |
59,904
+403
| +0.7% | +$131K | 1.73% | 20 |
|
2019
Q3 | $17.3M | Buy |
59,501
+18,335
| +45% | +$5.34M | 1.67% | 23 |
|
2019
Q2 | $12.1M | Buy |
+41,166
| New | +$12.1M | 1.16% | 28 |
|